ImmunityBio, Inc. — Director's Dealing 2019

Dec 17, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NantKwest, Inc. (NK)
CIK: 0001326110
Period of Report: 2019-12-13

Reporting Person: Thomas John C (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-12-13	Common Stock	S	10000	$2.48	Disposed	350069	Direct
2019-12-13	Common Stock	S	10000	$2.98	Disposed	340069	Direct
2019-12-16	Common Stock	S	10000	$3.14	Disposed	330069	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	13886	Indirect

Footnotes

F1: The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted on September 5, 2019 by the reporting person.

F2: Reported shares held by the John C Thomas Jr. Trustee Susan T Thomas U/W DTD 5/10/96.